Log in to save to my catalogue

Lymphoproliferative disorders in immunocompromised individuals and therapeutic antibodies for treatm...

Lymphoproliferative disorders in immunocompromised individuals and therapeutic antibodies for treatm...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1352294155

Lymphoproliferative disorders in immunocompromised individuals and therapeutic antibodies for treatment

About this item

Full title

Lymphoproliferative disorders in immunocompromised individuals and therapeutic antibodies for treatment

Publisher

London: Future Medicine Ltd

Journal title

Immunotherapy, 2013-04, Vol.5 (4), p.415-425

Language

English

Formats

Publication information

Publisher

London: Future Medicine Ltd

More information

Scope and Contents

Contents

The incidence of lymphoproliferative disease (LPD) is significantly higher in individuals who have congenital, acquired or iatrogenically induced immunodeficiency. Although there are a wide range of LPDs including lymphoma and leukemia, this article only covers LPDs in patients with impaired immune function, which are called immunodeficiency-associ...

Alternative Titles

Full title

Lymphoproliferative disorders in immunocompromised individuals and therapeutic antibodies for treatment

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1352294155

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1352294155

Other Identifiers

ISSN

1750-743X

E-ISSN

1750-7448

DOI

10.2217/imt.13.21

How to access this item